Loading…

Voxel S.A.VOX.WACompetitor analysis, valuation and peers

Poland · PLN·Health Care›Hospital/Nursing Management
Momentum leader 90
Mkt cap
$393M
US dollars, full cap
Free float
57%
of shares outstanding
$/day
$359,762
20-day average traded
Fwd P/E
13.6×
forward earnings
ROIC−WACC
+11.6 pp
WACC 9.9%
Hurdle
-11 pp
Req g minus delivered
Next earnings
8 days
26 Nov 2026
Close · PLNPLN 150.40
1D+0.9%
1W-0.4%
1M-2.1%
3M+12.6%
6M+59.5%
YTD+25.5%
1Y-3.0%
ATR %3.6%
52w lowhigh9.9% off high

What Voxel does

No business profile yet.

Voxel at a glance

Size Voxel (VOX.WA) is a Poland Health Care company (Hospital/Nursing Management) with a market value of $393M, the 65th largest of 82 Poland companies the cockpit tracks. Shares closed at PLN 150.40 on 18 Nov 2026.

Performance Over six months the shares gained 59.5%, against -5.6% for the median peer and +14.0% for the Poland market (cap-weighted) — highest of 19 in its peer set.

Growth Revenue grew 14.3% over the last twelve months (peer median +10.9%); the operating margin is 24.0% (peer median 10.2%).

Valuation It trades at 13.6× forward earnings against a peer median of 22.5× (2nd cheapest of 14).

Price implies For today's price to make sense, revenue must grow about 1% a year for seven years (Req g). Recent delivered growth is +12%, so the hurdle is -11 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 11.6 points above its cost of capital (9.9% WACC).

Next results Next results expected around 26 Nov 2026 (exchange calendar; dates can move).

Relative performance

10012515021 May 202621 Aug 202618 Nov 2026VOX.WA 153Peer median 93
Six months, rebased to 100: Voxel against the median of its 20 peers (local-currency closes).

Voxel financials

Reported figures in PLN; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenuePLN 641MPLN 584MPLN 508MPLN 424MPLN 361M
Revenue growth—+15%+20%+18%—
Gross profitPLN 192MPLN 169MPLN 155MPLN 140MPLN 107M
EBITDAPLN 212MPLN 186MPLN 174MPLN 149MPLN 120M
Net incomePLN 117MPLN 98.5MPLN 96.5MPLN 74.3MPLN 44.4M
Free cash flowPLN 93.3MPLN 32.4MPLN 42.6MPLN 74.2MPLN 54.6M
Capital expenditurePLN 83.3MPLN 75.8MPLN 70.6MPLN 44.3MPLN 31.0M
Total debtPLN 159MPLN 186MPLN 127MPLN 127MPLN 138M

Quarterly statements and history in the cockpit →

Voxel competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%0%+50%-20%0%+20%+40%151560623012392609INDRAMEDCO301103VMDQC7GHCARTEMISMEDKOVAIHCGGDSJLHLRHKPARKHOSPSVOX.WA6-month return →1-month return →
Up and to the right = strong over both horizons. Voxel is the large dot.

Fundamentals: revenue growth against valuation

0%+5%+10%+15%+20%0×25×50×75×15156062301239INDRAMEDCOVMDQC7GHCARTEMISMEDHCGCBAVJLHLPARKHOSPSVOX.WARevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Voxel is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%0%20%40%151560623012392609INDRAMEDCOKMCSHIL301103VMDQC7ARTEMISMEDKOVAIA50GDSCBAVPARKHOSPSVOX.WAGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Voxel is the large dot.

Voxel competitors and peer comparison

How Voxel compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Voxel against its 20 peers (data as of 18 Nov 2026)
MeasureVOX.WAPeer medianRank in peer set
1-month return-2.1%+2.1%10th lowest of 20
6-month return+59.5%-5.6%highest of 19
Distance from 52-week high-9.9%-22.3%7th highest of 21
Revenue growth (TTM)+14.3%+10.9%9th highest of 21
Operating margin24.0%10.2%highest of 21
Forward P/E13.6×22.5×2nd cheapest of 14
Growth the price implies (Req g, 7 yrs)1.2%7.2%5th least demanding of 17
Growth delivered (Del g)+12.2%+16.0%7th lowest of 17
Hurdle (Req g minus delivered)-11.0 pp-4.9 pp6th least demanding of 17
ROIC minus cost of capital+11.6 pp+0.6 pp5th highest of 21
EV / EBITDA8.1×14.6×4th cheapest of 18
Net debt / EBITDA0.6×0.3×9th most indebted of 18

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Voxel VOX.WAPoland$393M+59%+14%24%13.6×1.2%+12.2%
China Resources Medical 1515.HKHong Kong$393M-10%0%6%5.4×-7.5%+26.3%
Charm Care 6062.TJapan$402M+57%+6%11%15.3×-0.4%+16.4%
Bright Eye Hospital 301239.SZChina$377M-26%+11%9%41.5×-5.1%+15.5%
Bayzed Health 2609.HKHong Kong$375M-58%-2%5%n/a14.7%+9.2%
Indraprastha Medical INDRAMEDCO.NSIndia$351M0%+11%15%15.9×14.9%+19.3%
KMC Speciality Hospitals (India) KMCSHIL.NSIndia$346Mn/a+35%23%n/a19.0%+24.4%
Liaoning He Eye Hospital 301103.SZChina$342M-20%+3%4%n/a-4.2%+5.4%
Viemed Healthcare VMDUnited States$333M-9%+22%8%17.4×6.8%+15.5%
Q & M Dental Group (Singapore) QC7.SISingapore$326M-26%+16%9%31.6×7.7%+7.5%
Garofalo Health Care GHC.MIItaly$508M-3%+4%10%20.5×1.7%+18.3%
Artemis Medicare Services ARTEMISMED.NSIndia$582M+25%+15%13%42.3×48.5%+21.5%
Kovai Medical Center & Hospital KOVAI.NSIndia$759M+22%+17%21%n/a17.4%+18.1%
Thomson Medical A50.SISingapore$923M-18%+6%10%n/a21.2%+11.8%
HealthCare Global Enterprises HCG.NSIndia$955M-7%+13%8%88.8×n/an/a
Paras Healthcare PARASHLTH.NSIndia$962Mn/a+24%11%n/an/an/a
Ramsay Generale de Sante GDS.PAFrance$969M-25%+3%4%n/a6.1%+6.0%
Clinica Baviera CBAV.MCSpain$1.01B+2%+11%20%20.1×2.3%+19.7%
Jupiter Life Line Hospitals JLHL.NSIndia$1.01B+9%+17%16%48.8×n/an/a
Rhon-klinikum RHK.DEGermany$1.06B+15%+4%-51%22.5×n/an/a
Park Medi World PARKHOSPS.NSIndia$1.10B-4%+21%21%30.6×22.1%+10.2%

Questions

Which companies are Voxel's closest peers?
The cockpit's peer set: China Resources Medical (1515.HK), Charm Care (6062.T), Bright Eye Hospital (301239.SZ), Bayzed Health (2609.HK), Indraprastha Medical (INDRAMEDCO.NS), KMC Speciality Hospitals (India) (KMCSHIL.NS), Liaoning He Eye Hospital (301103.SZ), Viemed Healthcare (VMD).
Is Voxel expensive compared with its peers?
On forward p/e it trades at 13.6× against a peer median of 22.5×, 2nd cheapest of 14 in its peer set. For today's price to make sense, revenue must grow about 1% a year for seven years (Req g). Recent delivered growth is +12%, so the hurdle is -11 pp: the price already allows for a slowdown.
How has Voxel stock performed?
Over six months to 18 Nov 2026 the shares returned +59.5% against -5.6% for the median peer; over one year -3.0%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.